Detailed Information on Publication Record
2012
Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications
KŘEN, Leoš, Pavel FABIAN, Ondřej SLABÝ, Andrea JANÍKOVÁ, Ondřej SOUČEK et. al.Basic information
Original name
Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications
Authors
KŘEN, Leoš (203 Czech Republic), Pavel FABIAN (203 Czech Republic), Ondřej SLABÝ (203 Czech Republic, belonging to the institution), Andrea JANÍKOVÁ (203 Czech Republic), Ondřej SOUČEK (203 Czech Republic), Jaroslav ŠTĚRBA (203 Czech Republic), Zdenka KŘENOVÁ (203 Czech Republic), Jaroslav MICHÁLEK (203 Czech Republic, belonging to the institution) and Zdeněk KRÁL (203 Czech Republic, guarantor)
Edition
Pathology Research and Practice, Jena, Germany, Elsevier GmbH, 2012, 0344-0338
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.213
RIV identification code
RIV/00216224:14740/12:00060138
Organization unit
Central European Institute of Technology
UT WoS
000300602900007
Keywords in English
HLA-E; Hodgkin lymphoma; Microenvironment; Clinical stage
Tags
International impact, Reviewed
Změněno: 11/4/2013 14:05, Olga Křížová
Abstract
V originále
Although the role of the non-classical human leukocyte antigen E (HLA-E) was originally thought to be limited to the development of a maternal tolerance to a semiallogeneic fetal graft, it is now known that HLA-E exerts multiple immunoregulatory functions. The significance of the presence of HLA-E in neoplastic cells and/or backround microenvironment cells in classical Hodgkin lymphoma (cHL) is not well characterized. In our study, we evaluated the presence of HLA-E in both neoplastic and background cells in 40 cases of cHL. We found HLA-E in both neoplastic and background cells. There was a positive statistical correlation between the expression of HLA-E in neoplastic cells and the clinical stage of the disease, which indicates an immune-tolerogenic property of this multiple-purpose molecule. The presence of HLA-E in background cells seems to be prognostically neutral but its significance still needs to be determined. The mechanisms regulating the immunopathology of cHL neoplastic cells with respect to the presence of these molecule deserve further studies.
Links
ED1.1.00/02.0068, research and development project |
|